MX2011009205A - Proteinas de fusion de transcriptasa inversa estabilizada. - Google Patents

Proteinas de fusion de transcriptasa inversa estabilizada.

Info

Publication number
MX2011009205A
MX2011009205A MX2011009205A MX2011009205A MX2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A
Authority
MX
Mexico
Prior art keywords
reverse transcriptase
fusion proteins
protein
stabilized
stabilized reverse
Prior art date
Application number
MX2011009205A
Other languages
English (en)
Spanish (es)
Inventor
Alan M Lambowitz
Sabine Mohr
Georg Mohr
Eman Ghanem
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of MX2011009205A publication Critical patent/MX2011009205A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2011009205A 2009-03-04 2010-03-04 Proteinas de fusion de transcriptasa inversa estabilizada. MX2011009205A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15733209P 2009-03-04 2009-03-04
PCT/US2010/026165 WO2010102085A2 (en) 2009-03-04 2010-03-04 Stabilized reverse transcriptase fusion proteins

Publications (1)

Publication Number Publication Date
MX2011009205A true MX2011009205A (es) 2011-09-30

Family

ID=42710216

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009205A MX2011009205A (es) 2009-03-04 2010-03-04 Proteinas de fusion de transcriptasa inversa estabilizada.

Country Status (11)

Country Link
US (4) US10113156B2 (https=)
EP (2) EP2403941B1 (https=)
JP (2) JP5882064B2 (https=)
CN (1) CN102421791A (https=)
AU (1) AU2010221284B2 (https=)
BR (1) BRPI1009221A2 (https=)
CA (1) CA2754476A1 (https=)
IL (1) IL214913A (https=)
MX (1) MX2011009205A (https=)
WO (1) WO2010102085A2 (https=)
ZA (1) ZA201107207B (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
AU2012220596B2 (en) * 2011-02-23 2016-05-12 Board Of Regents Use of template switching for DNA synthesis
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
CN108368151B (zh) 2015-12-07 2022-11-15 生物辐射实验室股份有限公司 二聚逆转录酶
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
WO2019070843A1 (en) * 2017-10-03 2019-04-11 Board Of Regents, The University Of Texas System INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
WO2020252455A1 (en) 2019-06-13 2020-12-17 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
WO2021165273A1 (en) * 2020-02-17 2021-08-26 Leadxpro Ag Pro-macrobodies for the enhancement of structure research
CN116209756A (zh) 2020-03-04 2023-06-02 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
CA3189601A1 (en) 2020-07-24 2022-01-27 The General Hospital Corporation Enhanced virus-like particles and methods of use thereof for delivery to cells
CA3193099A1 (en) 2020-09-24 2022-03-31 David R. Liu Prime editing guide rnas, compositions thereof, and methods of using the same
EP4274894A2 (en) 2021-01-11 2023-11-15 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
JP2024530487A (ja) 2021-08-06 2024-08-21 ザ ブロード インスティテュート,インコーポレーテッド 改善されたプライムエディターおよび使用方法
EP4137582B1 (en) * 2021-08-17 2026-01-28 New England Biolabs, Inc. Rolling circle reverse transcription of circular rna
AU2022343268A1 (en) 2021-09-08 2024-03-28 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
WO2023102538A1 (en) 2021-12-03 2023-06-08 The Broad Institute, Inc. Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
WO2023205687A1 (en) 2022-04-20 2023-10-26 The Broad Institute, Inc. Improved prime editing methods and compositions
WO2023240137A1 (en) 2022-06-08 2023-12-14 The Board Institute, Inc. Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
EP4619515A1 (en) 2022-11-17 2025-09-24 The Broad Institute, Inc. Prime editor delivery by aav
WO2024168147A2 (en) 2023-02-09 2024-08-15 The Broad Institute, Inc. Evolved recombinases for editing a genome in combination with prime editing
WO2024206125A1 (en) 2023-03-24 2024-10-03 The Broad Institute, Inc. Use of prime editing for treating sickle cell disease
AU2024357861A1 (en) 2023-10-12 2026-04-23 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5654176A (en) 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US5736373A (en) * 1996-09-23 1998-04-07 Becton, Dickinson And Company Thermostable DNA polymerase from Bacillus pallidus
US7001745B1 (en) 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
US6436677B1 (en) 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
US7507412B2 (en) 2001-07-18 2009-03-24 Merck Patent Gmbh Glycoprotein VI fusion proteins
US7670807B2 (en) * 2004-03-10 2010-03-02 East Tennessee State Univ. Research Foundation RNA-dependent DNA polymerase from Geobacillus stearothermophilus
US7935509B2 (en) 2004-08-13 2011-05-03 New England Biolabs, Inc. Intracellular production of a nuclease

Also Published As

Publication number Publication date
AU2010221284A1 (en) 2011-10-27
IL214913A (en) 2017-06-29
WO2010102085A4 (en) 2011-01-06
AU2010221284B2 (en) 2015-10-01
US20180340158A1 (en) 2018-11-29
WO2010102085A2 (en) 2010-09-10
BRPI1009221A2 (pt) 2016-03-15
EP2403941A2 (en) 2012-01-11
EP2403941B1 (en) 2018-10-03
JP2015193666A (ja) 2015-11-05
US20180346890A1 (en) 2018-12-06
IL214913A0 (en) 2011-11-30
US10858636B2 (en) 2020-12-08
JP2012519489A (ja) 2012-08-30
US20120009630A1 (en) 2012-01-12
ZA201107207B (en) 2012-12-27
JP5882064B2 (ja) 2016-03-09
US10113156B2 (en) 2018-10-30
CN102421791A (zh) 2012-04-18
US10150955B2 (en) 2018-12-11
WO2010102085A3 (en) 2010-11-18
EP2403941A4 (en) 2012-09-05
CA2754476A1 (en) 2010-09-10
EP3415621A1 (en) 2018-12-19
US20160289652A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
MX2011009205A (es) Proteinas de fusion de transcriptasa inversa estabilizada.
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2012093833A3 (en) Genome engineering via designed tal effector nucleases
WO2010111686A3 (en) Labeled enzyme compositions, methods & systems
ATE477321T1 (de) Aviäre telomerase reverse transkriptase
EA201171325A1 (ru) Нуклеиновые кислоты, связывающиеся с гепсидином
WO2009135212A3 (en) Selective 5' ligation tagging of rna
EP4435100A3 (en) Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MX292528B (es) Beta-xilosidasas tolerantes al acido y termicas, genes que las codifican, organismos relacionados y metodos.
WO2015024017A3 (en) Rna polymerase, methods of purification and methods of use
WO2015157555A8 (en) Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
EP2032714A4 (en) CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF NUCLEIC ACID
WO2009045344A3 (en) Error-free amplification of dna for clonal sequencing
EP3461896A3 (en) Methods of transcription activator like effector assembly
EA201100001A3 (ru) Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
WO2012018639A3 (en) Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2010062779A3 (en) Modified dna polymerases
WO2013083264A8 (en) Dna polymerases with improved activity
WO2008094599A3 (en) Modified rna ligase for efficient 3' modification of rna
WO2010134939A3 (en) Mammalian genes involved in infection
WO2008023247A3 (en) Matrix attachment regions (mars) for increasing transcription and uses thereof
WO2013083263A8 (en) Dna polymerases with improved activity
WO2010014922A3 (en) Protein purification tags and uses thereof
WO2010039778A3 (en) Mammalian genes involved in infection

Legal Events

Date Code Title Description
FA Abandonment or withdrawal